Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models.
Saved in:
| Title: | Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models. |
|---|---|
| Authors: | Winter-Holt JJ, Bardelle C; BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Chiarparin E, Dale IL, Davey PRJ, Davies NL, Denz C; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Fillery SM, Guérot CM, Han F; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Hughes SJ, Kulkarni M; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Liu Z; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Milbradt A, Moss TA, Niu H; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Patel J, Rabow AA, Schimpl M, Shi J; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Sun D; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Yang D; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Guichard S; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2022 Feb 24; Vol. 65 (4), pp. 3306-3331. Date of Electronic Publication: 2022 Feb 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35133824 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Winter-Holt+JJ%22">Winter-Holt JJ</searchLink><br /><searchLink fieldCode="AU" term="%22Bardelle+C%22">Bardelle C</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chiarparin+E%22">Chiarparin E</searchLink><br /><searchLink fieldCode="AU" term="%22Dale+IL%22">Dale IL</searchLink><br /><searchLink fieldCode="AU" term="%22Davey+PRJ%22">Davey PRJ</searchLink><br /><searchLink fieldCode="AU" term="%22Davies+NL%22">Davies NL</searchLink><br /><searchLink fieldCode="AU" term="%22Denz+C%22">Denz C</searchLink>; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Fillery+SM%22">Fillery SM</searchLink><br /><searchLink fieldCode="AU" term="%22Guérot+CM%22">Guérot CM</searchLink><br /><searchLink fieldCode="AU" term="%22Han+F%22">Han F</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Hughes+SJ%22">Hughes SJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kulkarni+M%22">Kulkarni M</searchLink>; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Milbradt+A%22">Milbradt A</searchLink><br /><searchLink fieldCode="AU" term="%22Moss+TA%22">Moss TA</searchLink><br /><searchLink fieldCode="AU" term="%22Niu+H%22">Niu H</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Patel+J%22">Patel J</searchLink><br /><searchLink fieldCode="AU" term="%22Rabow+AA%22">Rabow AA</searchLink><br /><searchLink fieldCode="AU" term="%22Schimpl+M%22">Schimpl M</searchLink><br /><searchLink fieldCode="AU" term="%22Shi+J%22">Shi J</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Sun+D%22">Sun D</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Yang+D%22">Yang D</searchLink>; Pharmaron Beijing Co. Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Guichard+S%22">Guichard S</searchLink>; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2022 Feb 24; Vol. 65 (4), pp. 3306-3331. <i>Date of Electronic Publication: </i>2022 Feb 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35133824 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.jmedchem.1c01871 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3306 Titles: – TitleFull: Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Winter-Holt JJ – PersonEntity: Name: NameFull: Bardelle C – PersonEntity: Name: NameFull: Chiarparin E – PersonEntity: Name: NameFull: Dale IL – PersonEntity: Name: NameFull: Davey PRJ – PersonEntity: Name: NameFull: Davies NL – PersonEntity: Name: NameFull: Denz C – PersonEntity: Name: NameFull: Fillery SM – PersonEntity: Name: NameFull: Guérot CM – PersonEntity: Name: NameFull: Han F – PersonEntity: Name: NameFull: Hughes SJ – PersonEntity: Name: NameFull: Kulkarni M – PersonEntity: Name: NameFull: Liu Z – PersonEntity: Name: NameFull: Milbradt A – PersonEntity: Name: NameFull: Moss TA – PersonEntity: Name: NameFull: Niu H – PersonEntity: Name: NameFull: Patel J – PersonEntity: Name: NameFull: Rabow AA – PersonEntity: Name: NameFull: Schimpl M – PersonEntity: Name: NameFull: Shi J – PersonEntity: Name: NameFull: Sun D – PersonEntity: Name: NameFull: Yang D – PersonEntity: Name: NameFull: Guichard S IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 02 Text: 2022 Feb 24 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1520-4804 Numbering: – Type: volume Value: 65 – Type: issue Value: 4 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |